KDR and neoplasm: The significant reduction of tumour perfusion and VEGFR2-targeted MB under combined immunotherapy assessed by CEUS were paralleled by significant pro-immunogenic, pro-apoptotic, anti-angiogenic and anti-proliferative effects in immunohistochemistry.